Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging

[1]  R. Costa.  Bone and Joint Imaging. 2nd ed , 1997 .

[2]  M. Mack,et al.  Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. , 1996, Radiology.

[3]  M. Taupitz,et al.  Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. , 1995, Radiology.

[4]  A L Baert,et al.  Prolonged positive contrast enhancement with Gd‐EOB‐DTPA in experimental liver tumors: Potential value in tissue characterization , 1994, Journal of magnetic resonance imaging : JMRI.

[5]  M Lüning,et al.  Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging. , 1994, Radiology.

[6]  M. Bernardino,et al.  Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging. , 1993, Radiology.

[7]  Y. Ni,et al.  Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology. , 1993, Magnetic resonance imaging.

[8]  J. Mintorovitch,et al.  Acute liver rejection: evaluation with cell-directed MR contrast agents in a rat transplantation model. , 1993, Radiology.

[9]  M. Taupitz,et al.  Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging. , 1993, Radiology.

[10]  R. Brasch,et al.  Comparison of Gd‐EOB‐DTPA and Gd‐DTPA for contrast‐enhanced MR imaging of liver tumors , 1993, Journal of magnetic resonance imaging : JMRI.

[11]  R. Brasch,et al.  Evaluation of radiation-induced liver injury with MR imaging: comparison of hepatocellular and reticuloendothelial contrast agents. , 1992, Radiology.

[12]  R. Brasch,et al.  Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats. , 1992, Investigative radiology.

[13]  R. Brasch,et al.  Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases. , 1992, Radiology.

[14]  R. Brasch.  New directions in the development of MR imaging contrast media. , 1992, Radiology.

[15]  H. Weinmann,et al.  Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. , 1992, Radiology.

[16]  M. Bernardino,et al.  Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity. , 1992, Radiology.

[17]  T. Vogl,et al.  Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients. , 1992, Radiology.

[18]  H. Weinmann,et al.  A new lipophilic gadolinium chelate as a tissue‐specific contrast medium for MRI , 1991, Magnetic resonance in medicine.

[19]  B. Hamm,et al.  Manganese‐DPDP as a Hepatobiliary Contrast Agent in the Magnetic Resonance Imaging of Liver Tumors: Results of Clinical Phase II Trials in Germany Including 141 Patients , 1991, Investigative radiology.